Nuvation Bio NUVB Available-for-Sale Debt Securities - Amortized Cost
Available-for-Sale Debt Securities - Amortized Cost at other companies
Other financials
Where this comes from
Reported directly by Nuvation Bio in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost.
The official record: Nuvation Bio’s 10-K, filed March 2, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nuvation Bio's available-for-sale debt securities - amortized cost.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nuvation Bio's available-for-sale debt securities - amortized cost?
- Nuvation Bio (NUVB) reported available-for-sale debt securities - amortized cost of $222.75M in Q4 2025.
- How has Nuvation Bio's available-for-sale debt securities - amortized cost changed year-over-year?
- Nuvation Bio's available-for-sale debt securities - amortized cost decreased by 42.0% year-over-year, from $384.03M to $222.75M.
- What is the long-term trend for Nuvation Bio's available-for-sale debt securities - amortized cost?
- Over 4 years (2021 to 2025), Nuvation Bio's available-for-sale debt securities - amortized cost has grown at a -9.9% compound annual growth rate (CAGR), from $337.83M to $222.75M.
- What does available-for-sale debt securities - amortized cost mean?
- This is the cost basis of debt securities classified as available-for-sale, adjusted for amortization of premiums or discounts. It represents the value of the investment portfolio before accounting for current market price fluctuations. This provides a baseline for evaluating the performance of the company's liquid investment strategy.